BI
GILD icon

Bredin Investment’s Gilead Sciences GILD Stock Holding History

Bredin Investment’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-11,368
Closed -$711K – 74
2018
Q4 		$711K Hold
11,368
– – 0.67% 38
2018
Q3 		$878K Hold
11,368
– – 0.72% 35
2018
Q2 		$805K Hold
11,368
– – 0.62% 35
2018
Q1 		$857K Hold
11,368
– – 0.74% 32
2017
Q4 		$842K Buy
+11,368
New +$863K 0.68% 33

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bredin Investment's GILD Position: Q1 2019 in Review

Bredin Investment sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 11,368 shares — an estimated $711K sold.

Bredin Investment first reported a position in GILD in Q4 2017 and held it in 5 quarters. The position peaked at $878K in Q3 2018. 1,491 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

  • Bredin Investment reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
  • Bredin Investment sold 11,368 Gilead Sciences shares in Q1 2019, an estimated $711K.
  • Bredin Investment first reported a position in Gilead Sciences in Q4 2017 and held it in 5 quarters.
  • Bredin Investment's Gilead Sciences position peaked at $878K in Q3 2018.
  • 1,491 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Bredin Investment's 13F filing for Q1 2019, filed 23 Apr 2019.